Back to top

genetic-testing: Archive

Zacks Equity Research

Illumina (ILMN) Oncology Growth Aids Amid GRAIL Merger Hurdle

Illumina (ILMN) is making progress outside the United States to ensure all expecting families have access to NIPT.

ILMNNegative Net Change ALCNegative Net Change IDXXNegative Net Change SMLRNegative Net Change

Zacks Equity Research

Do Options Traders Know Something About Axsome (AXSM) Stock We Don't?

Investors need to pay close attention to Axsome (AXSM) stock based on the movements in the options market lately.

AXSMNegative Net Change

Zacks Equity Research

QIAGEN (QGEN) to Join DAX Riding on Molecular Diagnostics Feat

QIAGEN (QGEN) is experiencing significant improvements in non-COVID areas of its molecular diagnostics portfolio.

HSICNegative Net Change QGENNo Net Change NVSTNegative Net Change BRBRNegative Net Change

Urmimala Biswas

4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip

Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.

OMCLPositive Net Change IDXXNegative Net Change STAANegative Net Change VREXPositive Net Change

Zacks Equity Research

Illumina (ILMN), Grail Merger Sees Futher Regulatory Challenges

According to Illumina (ILMN), GRAIL will continue to operate as a separate company until the ongoing regulatory review by the EC is completed.

ILMNNegative Net Change HSICNegative Net Change NVSTNegative Net Change BRBRNegative Net Change